Ergomed Group

ergomed-cro.com
+49619690754-0

Ergomed Group

Otto-Volger-Straße 9b
65843 Frankfurt am Main
Germany
+49619690754-0
ergomed-cro.com
Profile News

About Ergomed Group

ERGOMED is an established international clinical development company offering contract clinical research and co-development partnerships to biotechnology and pharmaceutical companies world wide.

Read more about Ergomed Group
Facts about Ergomed Group
  • Focus : Service
  • Industry : Pharma

News about Ergomed Group

Ergomed Group

05-Oct-2017 | business & finance

Ergomed plc Completes Acquisition of PSR Group BV

Ergomed plc announces that, further to the Company's announcement on 28 September 2017, the acquisition of PSR Group BV ("PSR") has completed following the ...

Read news
Ergomed Group

11-May-2009 | business & finance

Ergomed Signs Co-Development Collaboration Agreement with Genzyme Corporation to Develop Tasidotin in Oncology

Ergomed announced that it has signed an agreement with Genzyme Corporation on the co-development of tasidotin, a novel dolastatin analogue that has shown ...

Read news
Show more news about Ergomed Group

Here you will find Ergomed Group

Last viewed contents

Ehrfeld Mikrotechnik BTS and Lonza cooperate in the microreactor technology

Go to page
Ets André Zalkin & Cie - Rueil-Malmaison, France

Ets André Zalkin & Cie - Rueil-Malmaison, France

Go to page

Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for Peptide Hybrid - Program will Focus on the Potential Treatment of Diabetes

Go to page
Emonta Pharma GmbH - Wien, Austria

Emonta Pharma GmbH - Wien, Austria

Go to page

Allon Appoints Dr. Michael Gold Chief Medical Officer

Go to page
16th BioVaria honours SurvivX and QUASAR Therapeutics with Startup Pitch & Partner Awards - Among the GO-Bio initial and ForTra projects, Innovade, Cognisa and Mallia Therapeutics were selected as winners

16th BioVaria honours SurvivX and QUASAR Therapeutics with Startup Pitch & Partner Awards - Among the GO-Bio initial and ForTra projects, Innovade, Cognisa and Mallia Therapeutics were selected as winners

Go to page

BioVisioN AG receives United States Patent for Peptide-Biomarker Discovery and Identification Technology

Go to page

Biophage signs a MOU with two US Companies for developing new generation of PDS® biosensors

Go to page

GATC refuses Frost & Sullivan Marketing Strategy Leadership Award

Go to page

Wyeth and Sienabiotech announce R.& D. collaboration in the field of neurodegenerative diseases - Agreement to maximise research synergies for new molecules active against Alzheimer's Disease

Go to page